Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Prognostic value of NT-proBNP at rest and peak exercise in patients with impaired left ventricular function.

Kallistratos MS, Pavlidis AN, Chamodraka ES, Varounis C, Dritsas A, Laoutaris ID, Manolis AJ, Cokkinos DV.

Angiology. 2012 Oct;63(7):516-21. doi: 10.1177/0003319711429328. Epub 2011 Dec 7.

PMID:
22156406
2.
4.

N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea.

Maeder MT, Ammann P, Rickli H, Schoch OD, Korte W, Hürny C, Myers J, Münzer T.

Sleep Breath. 2008 Mar;12(1):7-16.

PMID:
17906885
5.

Chronotropic and neurohumoral markers for the evaluation of functional capacity in patients with impaired left ventricular function.

Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.

Hellenic J Cardiol. 2008 Jan-Feb;49(1):26-32.

6.

Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients.

Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.

J Heart Lung Transplant. 2008 Nov;27(11):1251-6. doi: 10.1016/j.healun.2008.07.030.

PMID:
18971099
7.

Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing.

Guazzi M, Boracchi P, Labate V, Arena R, Reina G.

J Card Fail. 2012 Apr;18(4):313-20. doi: 10.1016/j.cardfail.2012.01.006. Epub 2012 Feb 17.

PMID:
22464773
8.

Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.

Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ.

J Card Fail. 2000 Jun;6(2):130-9.

PMID:
10908087
9.

No incremental clinical information of NT Pro BNP at peak exercise over resting levels in patients with impaired left ventricular function.

Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.

Int J Cardiol. 2007 Oct 1;121(2):221-3. Epub 2006 Dec 4.

PMID:
17145088
10.

The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.

Kubánek M, Goode KM, Lánská V, Clark AL, Cleland JG.

Eur J Heart Fail. 2009 Apr;11(4):367-77. doi: 10.1093/eurjhf/hfp003. Epub 2009 Jan 29.

11.

NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points.

Luchner A, Hengstenberg C, Löwel H, Buchner S, Schunkert H, Riegger GA, Holmer S.

J Card Fail. 2005 Jun;11(5 Suppl):S21-7.

PMID:
15948096
12.

Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.

David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.

Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. Epub 2007 Dec 18.

PMID:
18089624
13.

Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.

Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, Moschella S, Psaroudaki M, Del Forno D, Orio F, Vitale DF, Chiariello M, Vigorito C.

Eur J Cardiovasc Prev Rehabil. 2008 Feb;15(1):113-8. doi: 10.1097/HJR.0b013e3282f00990.

PMID:
18277196
14.

Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.

Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.

Int J Cardiol. 2008 Aug 18;128(2):244-9. Epub 2007 Jul 27.

PMID:
17673312
15.

Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.

Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J, Svensson SE.

Clin Endocrinol (Oxf). 2006 Dec;65(6):760-6.

PMID:
17121527
17.

Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.

Rothenburger M, Stypmann J, Bruch C, Wichter T, Hoppe M, Drees G, Berendes E, Huelsken G, Loeher A, Welp H, Röttger C, Schmid C, Scheld HH, Tjan TD.

J Heart Lung Transplant. 2006 May;25(5):596-602. Epub 2006 Apr 11.

PMID:
16678040
18.

NT-proBNP and BNP values in cardiac patients with different degree of left ventricular systolic dysfunction.

Kotaska K, Popelova J, Tiserova M, Telekes P, Vrzanova M, Bronsky J, Halacova M, Kukacka J, Prusa R.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006 Jul;150(1):125-30.

19.

NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.

Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S.

Coron Artery Dis. 2008 Nov;19(7):481-7. doi: 10.1097/MCA.0b013e32830b4d0e.

PMID:
18923244
20.

The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.

Tschöpe C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP.

Eur Heart J. 2005 Nov;26(21):2277-84. Epub 2005 Jul 13.

PMID:
16014646

Supplemental Content

Support Center